Articles On Impression Healthcare (ASX:IHL)

Title Source Codes Date
Incannex kicks off Phase 1 clinical trial for its anti-inflammatory treatment

Special Report: Along with Phase 1 trials for IHL-675A, the company also received a positive response with respect to its global patent application from the Patent Examiner. Incannex Healthcare (ASX:IHL) announced the latest key update for...

Stockhead IHL 17 hours ago
Incannex Healthcare begins clinical trial using IHL-675A soft gel capsules

Clinical stage cannabinoid and psychedelic medicine development company Incannex Healthcare (ASX: IHL) has started a phase 1 clinical trial assessing a soft gel capsule formulation of its multi-use drug candidate IHL-675A in healthy volunte...

SmallCaps IHL 17 hours ago
Incannex (ASX:IHL) share price up on patent application announcement

The Incannex Healthcare Ltd (ASX: IHL) share price stormed 5.45% higher to 29.5 cents after resuming trade this morning. In early afternoon, the share price has retreated to 28 cents, up 1.82% on its previous closing price. Shares in th...

Motley Fool IHL 5 days ago
Incannex files global patent for its IHL-42X sleep apnoea treatment and receives ethics approval to administer to patients every day in an extension trial

IHL is on track to obtain clinical results from its Phase 2b trial in the second half of this year. Clinical stage cannabinoid and psychedelic medicine company, Incannex Healthcare (ASX:IHL), continues to execute with a run of positive deve...

Stockhead IHL 5 days ago
Incannex files patent application for IHL-42X and receives ethics approval for open label extension

Clinical stage cannabinoid and psychedelic development company Incannex Healthcare (ASX: IHL) has filed an international patent application as part of the development program for its drug IHL-42X for the treatment of obstructive sleep apnoe...

SmallCaps IHL 5 days ago
ASX health stocks: AusCann (ASX:AC8) up 5pc after asking for approval of cannabis-based canine drug

The ASX Healthcare index rose by 0.45% this morning, compared with the broader index which fell by 0.80%, helped by medicinal cannabis company AusCann (ASX:AC8). It rose by 5% in morning trading. AusCann announced it has submitted the first...

Stockhead IHL 1 week ago
Here’s why Incannex (ASX:IHL) shares are in a trading halt

The Incannex Healthcare Ltd (ASX: IHL) share price won’t be going anywhere today.   Shares in the emerging pharmaceutical company were placed in a trading halt before markets opened. Here’s why. Incannex shares halted on patent update and...

Motley Fool IHL 1 week ago
Incannex Share Price Up on IHL-675A Manufacture Update (ASX:IHL)

The Incannex Healthcare [ASX:IHL] share price rose 5.5% in early trade after IHL engaged a firm to manufacture IHL-675A soft-gel capsules pending clinical trials. The post Incannex Share Price Up on IHL-675A Manufacture Update (ASX:IHL) app...

MoneyMorning IHL 1 week ago
Incannex Share Price Up on IHL-675A Manufacture Update (ASX:IHL)

The Incannex Healthcare [ASX:IHL] share price rose 5.5% in early trade after IHL engaged a firm to manufacture IHL-675A soft-gel capsules pending clinical trials. The post Incannex Share Price Up on IHL-675A Manufacture Update (ASX:IHL) app...

MoneyMorning IHL 1 week ago
Incannex secures complete supply chain solution for its anti-inflammatory multi-use drug

Incannex has engaged Procaps to develop and manufacture its IHL-675A soft-gel capsules in preparation for clinical trials. The company’s anti-inflammatory multi-use drug product will be developed with Procaps’ ́proprietary patented Unigel t...

Stockhead IHL 1 week ago
Market highlights and 5 ASX small caps to watch on Friday

Wall Street mixed as F45 makes US IPO debut There was no clear direction in US equities markets overnight, and like the previous day, the benchmarks finished in mixed territories again. The Dow Jones finished 0.15% higher, S&P 500 was l...

Stockhead IHL 1 week ago
Incannex Healthcare appoints Procaps to develop capsule formulations for drug IHL-675A

Specialised pharmaceutical manufacturer Procaps SA has been engaged by Incannex Healthcare (ASX: IHL) to develop the specific formulation for its drug IHL-675A using Procaps’ Unigel capsule technology. Under the terms of the deal, Procaps w...

SmallCaps IHL 1 week ago
Why this hidden gem in the Incannex product suite could be a global market winner

The company now has a targeted research pathway to clinical success, with strong proprietary protection as it moves towards commercialisation. As a market leader in the clinical development of cannabinoid and psychedelic based medical solut...

Stockhead IHL 1 month ago
ASX closes 1.8% lower as Fed updates drag bank stocks

Summary The ASX 200 closed sharply lower by 133.60 points or 1.81% at 7,235.30. The market witnessed a sharp, heavy sell-off on persistent concerns over hawkish outlook by the US Federal Reserve. All four big four lenders - Westpac, C...

Kalkine Media IHL 1 month ago
Global pharma leader Vectura will help Incannex develop its concussion treatment drug

The deal gives IHL a global partner to develop the drug and navigate the global regulatory backdrop. Incannex Healthcare (ASX:IHL) flagged another key step forward this morning in the clinical development and manufacture of its IHL-216A tre...

Stockhead IHL 1 month ago
Incannex Healthcare to develop IHL-216A formulation for traumatic brain injury clinical trials

Cannabinoid development company Incannex Healthcare (ASX: IHL) has announced it has engaged drug manufacturer Vectura Limited to develop the specific formulation required for clinical trials of IHL-216A, its lead drug for the treatment of t...

SmallCaps IHL 1 month ago
Market highlights and 5 ASX small caps to watch on Monday

Wall Street plummets on ‘Triple Witching day’ All major US indices fell on Friday, mostly on inflation worries as investors are concerned about an earlier than expected increase in rates. St Louis Fed Reserve chairman James Bullard’s commen...

Stockhead IHL 1 month ago
US growing approvals a ‘monumental’ step away from Trump moratorium on pot licensing

Last week the US government announced it would begin granting growing approvals to several companies for medicinal marijuana research, ending an informal moratorium on licence issuing which has been in place since the Trump administration....

Stockhead IHL 2 months ago
Incannex takes key step towards FDA approval for IHL-42X with new research partnership

The company has partnered with one of Australia’s leading sleep science research as the second test site for ongoing clinical trials.  Clinical-stage cannabis and psychedelics company Incannex Healthcare (ASX:IHL) has taken another importan...

Stockhead IHL 2 months ago
Incannex partners with University of WA as additional site for ongoing Phase 2b sleep apnoea trial

Clinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has engaged the University of Western Australia’s Centre for Sleep Science as an additional site for an ongoing trial investigating the effects of drug candida...

SmallCaps IHL 2 months ago
Market highlights and 5 ASX small caps to watch on Tuesday

Tech stocks fell hard on the eve of US CPI report All major indices fell overnight on inflation fears, with tech and growth stocks the major losers. The US Labour Department will release its inflation report on Wednesday, US time. The Dow J...

Stockhead IHL 2 months ago
First subsidised CBD oil shows promise for Incannex Healthcare’s own medical cannabis drugs in Australia

In a historic first, a medicinal cannabis drug has been listed on Australia’s Pharmaceutical Benefits Scheme (PBS), enabling Australians living with Dravet syndrome access to treatment for the rare form of epilepsy. Federal health minister...

SmallCaps IHL 2 months ago
Incannex Share Price Rises on Quarterly Report (ASX:IHL)

The Incannex share price was up 3.5%. The Incannex Healthcare Ltd [ASX:IHL] advanced its clinical trials in the December quarter while posting a cash balance of $10.4 million... The post Incannex Share Price Rises on Quarterly Report (ASX:...

MoneyMorning IHL 2 months ago
Here is why Australian healthcare shares Neuren and Medibio are on watch

Summary Neuren Pharmaceuticals obtained a Canadian patent grant for trofinetide, with a patent term that extends to January 2032. Health technology company Medibio Limited has secured a pre-submission meeting with the FDA for a new 510...

Kalkine Media IHL 2 months ago
Incannex highlights Q1 momentum with 4C update, shares rally again

The company is moving from strength to strength as it builds out its drug development pathway for the lucrative US market. Pharmaceutical cannabis and psychedelic company Incannex Healthcare (ASX:IHL) is coming off a busy quarter as it exec...

Stockhead IHL 2 months ago
ASX healthcare shares OVN and ECS trading in red despite positive March quarter 

Summary Oventus Medical witnessed growth in booked revenue and acceleration in telehealth bookings in Q3 FY21. ECS Botanics Holdings’ March 2021 quarter was action-packed with a major acquisition and multiple supply agreements. Despit...

Kalkine Media IHL 2 months ago
US banks can now legally do business with cannabis, as ASX-listed Incannex pushes its way into the country

The US cannabis market reacted in jubilation last week, after the Secure and Fair Enforcement (SAFE) Banking Act — which would make it legal for insurers and banks to work with the cannabis industry — was successfully passed by the House of...

Stockhead IHL 2 months ago
How Incannex is positioning to be the ‘next GW Pharma’, with CEO Joel Latham

Incannex provides investors the best of breed for medicinal cannabis and psychedelic therapy development – and they’re looking at an excursion to the USA For Incannex Healthcare (ASX:IHL) CEO Joel Latham, 2021 is shaping up as a big year a...

Stockhead IHL 2 months ago
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months

ASX pot stocks have run hot in recent months but eight in particular have been particularly rewarding for shareholders. Many pot stocks ran cold prior to COVID-19 as regulatory progress stalled and global markets didn’t take off. Australia...

Stockhead IHL 3 months ago
Weed Week: 4/20 can’t help ASX cannabis companies

April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open...

Stockhead IHL 3 months ago
Incannex (ASX:IHL) share price backtracks on FDA update

The Incannex Healthcare Ltd (ASX: IHL) share price is in reverse during late-afternoon trade. This comes despite the company’s positive pre-investigational new drug application (pre-IND) meeting with the United States Food and Drug Adminis...

Motley Fool IHL 3 months ago
Incannex gets more good news, as FDA approves expanded development pathway for its IHL-675 treatment

Pharmaceutical cannabis and psychedelic medicine company Incannex Healthcare (ASX:IHL) continues to execute on its multi-channel development pathway for clinically-proven cannabinoid treatments. And the company announced some more good news...

Stockhead IHL 3 months ago
Incannex Healthcare plans US regulatory pathway for IHL-675A in treating multiple inflammatory conditions

Clinical stage pharmaceutical development company Incannex Healthcare (ASX: IHL) has held a pre-investigational new drug application meeting with the US Food and Drug Administration (US FDA) to discuss the regulatory pathway for lead candid...

SmallCaps IHL 3 months ago
Why were Australian healthcare shares EX1 and RAC trending today?

Summary Exopharm obtained firm commitments from institutional and sophisticated investors to raise a total of AU$12 million. Race Oncology announced that its new Chief Medical Officer, Dr David Fuller, is set to join on 1 July 2021....

Kalkine Media IHL 3 months ago
With their mind-blowing medical potential, are hallucinogens the next ASX ‘pot stock’ equivalent?

The mere mention of magic mushrooms, ecstasy or ketamine is enough to send parents of teenagers into conniptions. But are these so-called party drugs poised to follow cannabis into the realm of a medical treatment within a legitimate listed...

SmallCaps IHL 3 months ago
Incannex granted meeting with FDA over CBD drug cocktail

Special Report: Incannex Healthcare (ASX:IHL) is making steady progress on its hydroxychloroquine (HCQ)/cannabidiol (CBD) drug combination and will be meeting with US regulators shortly on an approval pathway. The Melbourne-based pharmaceut...

Stockhead IHL 4 months ago
Incannex Healthcare Share Price Up on FDA Meeting (ASX:IHL)

The pharmaceutical development company, Incannex Healthcare Ltd [ASX:IHL] share price is up after announcing a pre-IND meeting with the US FDA. At 2:30pm today, the IHL share price was up 5%... The post Incannex Healthcare Share Price Up o...

MoneyMorning IHL 4 months ago
Why the Incannex (ASX:IHL) share price is climbing 5% this morning

The Incannex Healthcare Ltd (ASX: IHL) share price is climbing on the back of a positive update regarding its therapy, IHL-675A. At the time of writing, the healthcare company’s shares are up 5%, trading at 21 cents. What did Incannex anno...

Motley Fool IHL 4 months ago
Incannex Healthcare secures pre-IND meeting with US FDA to progress IHL-675A in treating SAARDS and ARDS

Incannex Healthcare (ASX: IHL) will confer with the United States Food and Drug Administration after the body granted a pre-investigational new drug meeting regarding progressing the company’s IHL-675A drug in preventing acute respiratory d...

SmallCaps IHL 4 months ago
1 in 10 COVID survivors in Britain still suffer symptoms; ASX cannabis stock Bod wants to help

Cannabis stock Bod Australia (ASX:BDA) has entered the fight against what is known as “long-COVID”.   What is ‘long-COVID’? “Long-COVID” occurs when people suffer COVID-19 symptoms for several weeks of months after the initial onset of symp...

Stockhead IHL 4 months ago
Incannex Healthcare Shares Up on Arthritis Treatment Test (ASX:IHL)

Incannex Healthcare share price [ASX:IHL] is up today after its ASX update shows positive results from IHL’s arthritis treatment test. The Incannex share price is up 9.7% as of 3:00pm today... The post Incannex Healthcare Shares Up on Arth...

MoneyMorning IHL 4 months ago
Incannex will pursue a SIXTH possible use for its experimental drug cocktail: treating rheumatoid arthritis

Special Report: Incannex Healthcare (ASX:IHL) hydroxychloroquine/cannabidiol (CBD) cocktail is turning into a veritable wonder drug – at least in rodents. ... Read More The post Incannex will pursue a SIXTH possible use for its experimental...

Stockhead IHL 4 months ago
Why are Incannex Healthcare (ASX:IHL) shares riding high today?

Source: Chinnapong,Shutterstock Summary Clinical stage pharmaceutical development player Incannex Healthcare has reported encouraging outcomes for its lead candidate, IHL-675A, from an animal study. The Company updated that these find...

Kalkine Media IHL 4 months ago
Here’s why the Incannex (ASX:IHL) share price is up 10% today.

Incannex Healthcare Ltd (ASX: IHL) shares are up again today as the company announced its new CBD-based drug is more effective in treating rheumatoid arthritis than currently available medications. The Incannex share price opened nearly 15...

Motley Fool IHL 4 months ago
Incannex Healthcare study results point to IHL-675A as a treatment option for rheumatoid arthritis

Positive results from an in vivo study model using Incannex Healthcare’s (ASX: IHL) lead candidate IHL-675A have triggered the launch of a sixth clinical program investigating the benefits of the drug on the treatment of rheumatoid arthriti...

SmallCaps IHL 4 months ago
Up 300% in 1 year, what’s driving the Incannex Healthcare (ASX:IHL) share price?

The Incannex Healthcare Ltd (ASX: IHL) share price, which has shot up 310% in the past 12 months, has remained relatively flat in today’s trade. We take a look at the ASX healthcare share’s latest announcement on its accelerated drug study...

Motley Fool IHL 4 months ago
Incannex Healthcare and Monash Trauma Group to undertake sports concussion study using model developed by the NFL

Incannex Healthcare (ASX: IHL) has revealed it will work with Monash Trauma Group on an “extensive” in vivo study evaluating the protective effect of IHL-216A in sports concussion. Monash Trauma Group is a specialised team of academic resea...

SmallCaps IHL 4 months ago
Incannex Healthcare Share Price Down Despite Positive Results (ASX:IHL)

Shares trading in medicinal cannabinoid producer Incannex Healthcare Ltd [ASX:IHL] share price are flat today, despite posting positive results in its half-yearly report. The IHL share price is up 2.27% to trade at 22.5 cents per share.......

MoneyMorning IHL 5 months ago
Greenlab signs medicinal cannabis supply deal with Australia’s largest distributor Cannvalate

Biotechnology company Greenlab Australia has secured a two-year deal to supply pharmaceutical-grade, cannabinoid products to Australian medicinal cannabis distributor Cannvalate Pty Ltd for sales to approved patients. Under the non-exclusiv...

SmallCaps IHL 5 months ago
Incannex Healthcare Share Price up on Positive Results (ASX:IHL)

The share price of Incannex Healthcare Ltd (ASX:IHL) is up a further 15.9%, trading at 25.5 cents. After a dormant period, the IHL share price sprang to life starting in November... The post Incannex Healthcare Share Price up on Positive R...

MoneyMorning IHL 5 months ago